SCHEMBL31663547

SCHEMBL31663547

N#Cc1cc(-c2cccc(-c3ccccc3)n2)cc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 4/20 0.44
ADORA1 P30542 2/20 0.44
ADORA2A P29274 1/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 6/20 0.43
ALDH1A1 P00352 5/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 2/20 0.43
RXFP1 Q9HBX9 2/20 0.43
THRB P10828 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
NPSR1 Q6W5P4 4/20 0.42
CYP1A2 P05177 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
SQOR Q9Y6N5 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663512 0.89 ADORA1 (0.49) KMT2AMEN1L3MBTL1ADORA1ADORA2A
SCHEMBL31663529 0.89 TGFBR1 (0.46) L3MBTL1KDM4EALDH1A1HTTLMNA
SCHEMBL31663508 0.84 GRIA1 (0.51) KDM4EALDH1A1HTTLMNARXFP1
SCHEMBL31663532 0.81 NPSR1 (0.44) L3MBTL1ADORA1ADORA2AMAPK1KDM4E
SCHEMBL31663548 0.79 ALDH1A1 (0.49) L3MBTL1ADORA2AMAPK1KDM4EALDH1A1
SCHEMBL31663633 0.77 PIK3CA (0.48) L3MBTL1ADORA1ADORA2AKDM4EALDH1A1
SCHEMBL23296289 0.76 KMT2A (0.57) KMT2AMEN1RAB9AL3MBTL1ADORA1
SCHEMBL31663534 0.76 KMT2A (0.57) KMT2AMEN1RAB9AL3MBTL1ADORA1
SCHEMBL31663569 0.75 CYP11B2 (0.47) ADORA1ADORA2AKDM4EALDH1A1RXFP1
SCHEMBL7220074 0.74 ALDH1A1 (0.47) KMT2AMEN1RAB9AL3MBTL1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 KMT2A 4132/4885MEN1 3119/4885RAB9A 3734/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 KMT2A 4132/4885MEN1 3119/4885RAB9A 3734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.